Sanders-Brown Research Hints at Underlying Cause for Alzheimer's Drug Trial Failures

Sanders-Brown Research Hints at Underlying Cause for Alzheimer's Drug Trial Failures

Because Alzheimer’s disease (AD) is the leading cause of dementia, many people use the two terms interchangeably. But inadequate blood flow to the brain due to microinfarcts, mini-strokes, or strokes is a hallmark of a disease called Vascular Cognitive Impairment and Dementia (VCID).

UK Sanders-Brown Center on Aging Receives $8.25 Million to Continue Alzheimer's Research

UK Sanders-Brown Center on Aging Receives $8.25 Million to Continue Alzheimer's Research

The University of Kentucky Sanders-Brown Center on Aging Alzheimer's Disease Center (ADC) has been awarded an $8.25 million, five-year grant from the National Institutes of Health (NIH) to continue and further research and clinical initiatives geared toward treating Alzheimer's disease.

Sanders-Brown Laboratories Showcase Work on Alzheimer’s Disease, Traumatic Brain Injury

Sanders-Brown Laboratories Showcase Work on Alzheimer’s Disease, Traumatic Brain Injury

The laboratories of University of Kentucky researchers Anika Hartz, Ph.D., and Christopher Norris, Ph.D., published research studying the pathologies of Alzheimer’s disease and traumatic brain injury (TBI), respectively, in the most recent issue of The Journal of Neuroscience.